P475 Potential of molecular remission: tissue neutrophil elastase is better than histological activity for predicting long-term relapse in patients with Ulcerative Colitis in endoscopic remission

Y K Jun,J A Lee,Y Choi,C M Shin,Y S Park,N Kim,D H Lee,H J Oh,H Yoon

DOI: https://doi.org/10.1093/ecco-jcc/jjad212.0605

2024-01-01

Journal of Crohn's and Colitis

Abstract:Abstract Background Growing interest exists in deep remission, beyond clinical and endoscopic remission, to enhance long-term prognosis in patients with ulcerative colitis (UC). Our study aimed to evaluate the risk of relapse according to tissue expression levels of calprotectin and neutrophil elastase (NE) in patients with quiescent UC. Methods Rectal biopsies were performed on 218 patients with UC in clinical and endoscopic remission. Histological activity was prospectively scored using the Robarts Histological Index. Tissue calprotectin and NE levels were evaluated using immunohistochemistry. Clinical relapse was defined as the requirement for medical therapy escalation, systemic steroid administration, UC-related emergency room visits, hospitalization, or surgery. Optimal tissue calprotectin and NE cutoffs for relapse were determined using log-rank analysis. A Kaplan–Meier analysis was performed to assess the cumulative incidence of clinical relapse, and a Cox proportional hazard analysis was conducted to identify the risk factors for clinical relapse. Results Tissue calprotectin and NE levels were significantly higher in patients with histological activity than in those in histological remission (P < 0.001, respectively). The optimal cutoffs of tissue calprotectin and NE for relapse were 10.61 /mm2 and 22.08 /mm2, respectively. The 3-year clinical relapse risk was significantly lower in the low tissue NE group than in the high tissue NE group (P = 0.009); however, it did not differ between the low- and high-tissue calprotectin group (P = 0.094) (Figure). In multivariate analyses, a low level of tissue NE expression (adjusted hazard ratio [aHR] = 0.453, 95% confidence interval [CI] = 0.225–0.911, P = 0.026) and maintenance treatment using biologics (aHR = 0.368, 95% CI = 0.141–0.962) were independently associated with a lower risk of 3-year clinical relapse, but previous steroid exposure was independently related to increase the risk of 3-year clinical relapse (aHR = 2.824, 95% CI = 1.298–6.141) (Table). The histological index and tissue calprotectin did not have influence on the 3-year clinical relapse. Conclusion In patients with UC who have achieved clinical and endoscopic remission, tissue expression of NE is a better predictor of long-term relapse than histological activity.

gastroenterology & hepatology